Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Lord’s Mark Industries has received Central Licensing Authority approval to manufacture the LordsMed HIV 1&2 Self Test.

When timelines compress, it becomes harder to pressure-test assumptions, document decisions thoroughly and make sure ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

Explore the first test and impressions of NVIDIA's Nemotron 3 Nano Omni, a 30B multimodal model designed for fast local and ...

Lord’s Mark Industries Ltd. today announced that it has received approval from the Central Licensing Authority (Licence No.

Discusses Live Demonstration of withZeta.ai Platform for AI-Driven Oncology Drug Discovery April 30, 2026 8:30 AM ...

Digital melt flow indexers, such as the MP1500, enhance testing efficiency and precision, adapting to the evolving needs of ...

Chief AI officer” isn’t a classic Hollywood power title like “head of business development” or “social-media crisis manager ...

As enterprises move from AI pilots to production deployments, engineering teams face a harder challenge than model selection: turning prototypes into secure, scalable software that works inside ...

Q1 2026 Earnings Call April 30, 2026 3:00 AM EDTCompany ParticipantsPietro Zollino - Head of Corporate Communications & ...

Rotating detonation rocket engines work differently than traditional rockets to maximize thrust while using less fuel—an ...